Neural correlates of change in major depressive disorder anhedonia following open-label ketamine February 17, 2015
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences? February 9, 2015
Ex vivo effects of ibogaine on the activity of antioxidative enzymes in human erythrocytes February 7, 2015
Ex vivo effects of ibogaine on the activity of antioxidative enzymes in human erythrocytes February 7, 2015
The Effect of Repeated Ketamine Infusion Over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report February 6, 2015
Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers February 4, 2015
Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society February 1, 2015
Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia February 1, 2015
